301 related articles for article (PubMed ID: 11776318)
21. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
Wada H; Tanigawa M; Takagi M; Suzuki H; Mori Y; Ohta T; Kobayashi T; Kita K; Tanaka I; Yamaguchi T
Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
[TBL] [Abstract][Full Text] [Related]
22. [Plasma factor VII levels in disseminated intravascular coagulation].
Kario K; Matsuo T; Yamamoto K; Kobayashi H
Rinsho Byori; 1991 Jul; 39(7):683-8. PubMed ID: 1920859
[TBL] [Abstract][Full Text] [Related]
23. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.
de Boer JP; Creasy AA; Chang A; Roem D; Brouwer MC; Eerenberg AJ; Hack CE; Taylor FB
Circ Shock; 1993 Jan; 39(1):59-67. PubMed ID: 7683256
[TBL] [Abstract][Full Text] [Related]
24. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
25. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
26. [Alpha 2plasmin-inhibitor . plasmin complex (PIC)--useful diagnostic and prognostic parameter].
Taniguchi T; Matsuo T; Hishikawa R; Yamaguchi A; Akato S; Shibatouge M
Rinsho Byori; 1991 Jul; 39(7):714-9. PubMed ID: 1833570
[TBL] [Abstract][Full Text] [Related]
27. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
Koyama T; Kakishita E; Nakai Y; Okamoto E
Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
[TBL] [Abstract][Full Text] [Related]
28. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
[TBL] [Abstract][Full Text] [Related]
29. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
30. A comparison of haemocoagulation tests in the experimental endotoxin model DIC and in rats whole-body irradiated by 250 Gy.
Hlousková D; Polívková J; Pospísil J; Kase F
Sb Lek; 1993; 94(1):31-8. PubMed ID: 7991995
[TBL] [Abstract][Full Text] [Related]
31. Disseminated intravascular coagulation (DIC) in rabbit haemorrhagic disease.
Ueda K; Park JH; Ochiai K; Itakura C
Jpn J Vet Res; 1992 Dec; 40(4):133-41. PubMed ID: 1338394
[TBL] [Abstract][Full Text] [Related]
32. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor.
Taylor FB
Prog Clin Biol Res; 1994; 388():175-94. PubMed ID: 7831358
[TBL] [Abstract][Full Text] [Related]
33. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
[TBL] [Abstract][Full Text] [Related]
34. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
Dickneite G; Czech J; Keuper H
Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
[TBL] [Abstract][Full Text] [Related]
35. Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma.
Blombäck M; Eklund J; Hellgren M; Lagerkranser M; Swedenborg J
Scand J Clin Lab Invest Suppl; 1985; 178():15-23. PubMed ID: 3867116
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis of defibrination syndromes in infectious pathology].
Samama M
Ann Biol Clin (Paris); 1984; 42(1):41-5. PubMed ID: 6731953
[TBL] [Abstract][Full Text] [Related]
37. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
[TBL] [Abstract][Full Text] [Related]
38. [Abnormality of blood coagulation before onset of DIC--risk factors for DIC].
Wada H; Takagi M; Suzuki H; Deguchi K; Shirakawa S
Rinsho Byori; 1990 Jul; Suppl 86():134-41. PubMed ID: 2232234
[No Abstract] [Full Text] [Related]
39. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
Iijima K
Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
[No Abstract] [Full Text] [Related]
40. Effects of superoxide dismutase and catalase on disseminated intravascular coagulation in rats.
Yoshikawa T; Murakami M; Yoshida N; Seto O; Kondo M
Thromb Haemost; 1983 Dec; 50(4):869-72. PubMed ID: 6665768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
